Coordinated regulation of fat-specific and liver-specific glycerol channels, aquaporin adipose and aquaporin 9

Diabetes

Volumn 51, Issue 10, 2002, Pages 2915-2921

  Kuriyama, Hiroshi ^a   Shimomura, Iichiro ^a   Kishida, Ken ^a   Kondo, Hidehiko ^a   Furuyama, Naoki ^a   Nishizawa, Hitoshi ^a   Maeda, Norikazu ^a   Matsuda, Morihiro ^a   Nagaretani, Hiroyuki ^a   Kihara, Shinji ^a   Nakamura, Tadashi ^a   Tochino, Yoshihiro ^a   Funahashi, Tohru ^a   Matsuzawa, Yuji ^a  

^a OSAKA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AQUAPORIN; AQUAPORIN 9; GLUCOSE; GLYCEROL; MESSENGER RNA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DIET RESTRICTION; GLUCONEOGENESIS; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; GLYCEROL BLOOD LEVEL; HYPERINSULINEMIA; INSULIN RESISTANCE; LIVER LEVEL; MALE; MOLECULAR CLONING; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION;

EID: 0036787385     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.51.10.2915     Document Type: Article

References (43)

1. Ramsay TG: Fat cells. Endocrinol Metab Clin North Am 25:847-870, 1996
2. Coppack SW, Jensen MD, Miles JM: In vivo regulation of lipolysis in humans. J Lipid Res 35:177-193, 1994
3. Shimomura I, Tokunaga K, Kotani K, Keno Y, Yanase-Fujiwara M, Kanosue K, Jiao S, Funahashi T, Kobatake T, Yamamoto T, Matsuzawa Y: Marked reduction of acyl-CoA synthetase activity and mRNA in intra-abdominal visceral fat by physical exercise. Am J Physiol 265:E44-E50, 1993
4. Arner P, Kriegholm E, Engfeldt P, Bolinder J: Adrenergic regulation of lipolysis in situ at rest and during exercise. J Clin Invest 85:893-898, 1990
5. Reaven GM: Role of insulin resistance in human disease. Diabetes 37:1595-1607, 1988
6. Kaplan NM: How bad are diuretic-induced hypokalemia and hypercholesterolemia? Arch Intern Med 149:1514-1520, 1989
7. Kissebah AH, Vydelingum N, Murray R, Evans DJ, Hartz AJ, Kalkhoff RK, Adams PW: Relation of body fat distribution to metabolic complications of obesity. J Clin Endocrinol Metab 54:254-260, 1982
8. DeFronzo RA, Ferrannini E: Insulin resistance: a multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease. Diabetes Care 14:173-194, 1991
9. Matsuzawa Y, Shimomura I, Nakamura T, Keno Y, Tokunaga K: Pathopysiology and pathogenesis of visceral fat obesity. Ann N Y Acad Sci 676:270-278, 1993
10. Baynes C, Henderson AD, Hughes CL, Richmond W, Johnston DG, Elkeles RS: Determinants of mild fasting hypertriglyceridaemia in non-insulin-dependent diabetes. J Intern Med 229:267-273, 1991
11. Large V, Arner P: Regulation of lipolysis in humans: pathophysiological modulation in obesity, diabetes, and hyperlipidaemia. Diabetes Metab 24:409-418, 1998
12. Kuriyama H, Yamashita S, Shimomura I, Funahashi T, Ishigami M, Aragane K, Miyaoka K, Nakamura T, Takemura K, Man Z, Toide K, Nakayama N, Fukuda Y, Lin MC, Wetterau JR, Matsuzawa Y: Enhanced expression of hepatic acyl-coenzyme A synthetase and microsomal triglyceride transfer protein messenger RNAs in the obese and hypertriglyceridemic rat with visceral fat accumulation. Hepatology 27:557-562, 1998
13. Baba H, Zhang XJ, Wolfe RR: Glycerol gluconeogenesis in fasting humans. Nutrition 11:149-153, 1995
14. Hetenyi G Jr: Gluconeogenesis in vivo. Am J Physiol 249:R792-R793, 1985
15. Landau BR, Wahren J, Chandramouli V, Schumann WC, Ekberg K, Kalhan SC: Contributions of gluconeogenesis to glucose production in the fasted state. J Clin Invest 98:378-385, 1996
16. Peroni O, Large V, Beylot M: Measuring gluconeogenesis with [2-13C]glycerol and mass isotopomer distribution analysis of glucose. Am J Physiol 269:E516-E523, 1995
17. Peroni O, Large V, Odeon M, Beylot M: Measuring glycerol turnover, gluconeogenesis from glycerol, and total gluconeogenesis with [2-13C] glycerol: role of the infusion-sampling mode. Metabolism 45:897-901, 1996
18. Jensen MD, Chandramouli V, Schumann WC, Ekberg K, Previs SF, Gupta S, Landau BR: Sources of blood glycerol during fasting. Am J Physiol Endocrinol Metab 281:E998-E1004, 2001
19. Engel A, Fujiyoshi Y, Agre P: The importance of aquaporin water channel protein structures. EMBO J 19:800-806, 2000
20. Verkman AS, Mitra AK: Structure and function of aquaporin water channels. Am J Physiol 278:F13-F28, 2000
21. Kuriyama H, Kawamoto S, Ishida N, Ohno I, Mita S, Matsuzawa Y, Matsubara K, Okubo K: Molecular cloning and expression of a novel human aquaporin from adipose tissue with glycerol permeability. Biochem Biophys Res Commun 241:53:-55, 1997
22. Kishida K, Kuriyama H, Funahashi T, Shimomura I, Kihara S, Ouchi N, Nishida M, Nishizawa H, Matsuda M, Takahashi M, Hotta K, Nakamura T, Yamashita S, Tochino Y, Matsuzawa Y: Aquaporin adipose, a putative glycerol channel in adipocytes. J Biol Chem 275:20896-20902, 2000
23. Kishida K, Shimomura I, Kondo H, Kuriyama H, Makino Y, Nishizawa H, Maeda N, Matsuda M, Ouchi N, Kihara S, Kurachi Y, Funahashi T, Matsuzawa Y: Genomic structure and insulin-mediated repression of the aquaporin adipose (AQPap), adipose-specific glycerol channel. J Biol Chem 276:36251-36260, 2001
24. Kondo H, Shimomura I, Kishida K, Kuriyama H, Makino Y, Nishizawa H, Matsuda M, Maeda N, Nagaretani H, Kihara S, Kurachi Y, Nakamura T, Funahashi T, Matsuzawa Y: Human aquaporin adipose (AQPap) gene. Eur J Biochem 269:1814-1826, 2002
25. Kishida K, Shimomura I, Nishizawa H, Maeda N, Kuriyama H, Kondo H, Matsuda M, Nagaretani H, Ouchi N, Hotta K, Kihara S, Kadowaki T, Funahashi T, Matsuzawa Y: Enhancement of the aquaporin adipose gene expression by a peroxisome proliferator-activated receptor gamma. J Biol Chem 276:48572-48579, 2001
26. Tsukaguchi H, Shayakul C, Berger UV, Mackenzie B, Devidas S, Guggino WB, van Hoek AN, Hediger MA: Molecular characterization of a broad selectivity neutral solute channel. J Biol Chem 273:24737-24743, 1998
27. O'Brien RM, Streeper RS, Ayala JE, Stadelmaier BT, Hornbuckle LA: Insulin-regulated gene expression. Biochem Soc Trans 29:552-558, 2001
28. Tomizawa M, Kumar A, Perrot V, Nakae J, Accili D, Rechler MM, Kumaro A: Insulin inhibits the activation of transcription by a C-terminal fragment of the forkhead transcription factor FKHR: a mechanism for insulin inhibition of insulin-like growth factor-binding protein-1 transcription. J Biol Chem 275:7289-7295, 2000
29. Shimomura I, Bashmakov Y, Ikemoto S, Horton JD, Brown MS, Goldstein JL: Insulin selectively increases SREBP-1c mRNA in the livers of rats with streptozotocin-induced diabetes. Proc Natl Acad Sci U S A 96:13656-13661, 1999
30. Shimomura I, Matsuda M, Hammer RE, Bashmakov Y, Brown MS, Goldstein JL: Decreased IRS-2 and increased SREBP-1c lead to mixed insulin resistance and sensitivity in livers of lipodystrophic and ob/ob mice. Mol Cell 6:77-86, 2000
31. Arai K, Lee K, Berthiaume F, Tompkins RG, Yarmush ML: Intrahepatic amino acid and glucose metabolism in a D-galactosamine-induced rat liver failure model. Hepatology 34:360-371, 2001
32. Burns SP, Murphy HC, Iles RA, Cohen RD: Lactate supply as a determinant of the distribution of intracellular pH within the hepatic lobule. Biochem J 358:569-571, 2001
33. Tsukaguchi H, Weremowicz S, Morton CC, Hediger MA: Functional and molecular characterization of the human neutral solute channel aquaporin-9. Am J Physiol 277:F685-F696, 1999
34. Ishibashi K, Kuwahara M, Gu Y, Tanaka Y, Marumo F, Sasaki S: Cloning and functional expression of a new aquaporin (AQP9) abundantly expressed in the peripheral leukocytes permeable to water and urea, but not to glycerol. Biochem Biophys Res Commun 244:268-274, 1998
35. Westergaard N, Madsen P, Lundgren K: Characterization of glycerol uptake and glycerol kinase activity in rat hepatocytes cultured under different hormonal conditions. Biochim Biophys Acta 1402:261-268, 1998
36. Nandan SD, Beale EG: Regulation of phosphoenolpyruvate carboxykinase mRNA in mouse liver, kidney, and fat tissues by fasting, diabetes, and insulin. Lab Anim Sci 42:473-477, 1992
37. O'Brien RM, Granner DK: Regulation of gene expression by insulin. Physiol Rev 76:1109-1161, 1996
38. Hall RK, Yamasaki T, Kucera T, Waltner-Law M, O'Brien R, Granner DK: Regulation of phosphoenolpyruvate carboxykinase and insulin-like growth factor-binding protein-1 gene expression by insulin: the role of winged helix/forkhead proteins. J Biol Chem 275:30169-30175, 2000
39. Andrikopoulos S, Proietto J: The biochemical basis of increased hepatic glucose production in a mouse model of type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia 38:1389-1396, 1995
40. Previs SF, Brunengraber H: Methods for measuring gluconeogenesis in vivo. Curr Opin Clin Nutr Metab Care 1:461-465, 1998
41. Elkjaer M, Vajda Z, Nejsum LN, Kwon T, Jensen UB, Amiry-Moghaddam M, Frokiaer J, Nielsen S: Immunolocalization of AQP9 in liver, epididymis, testis, spleen, and brain. Biochem Biophys Res Commun 276: 1118-1128, 2000
42. Di Guglielmo GM, Drake PG, Baass PC, Authier F, Posner BI, Bergeron JJ: Insulin receptor internalization and signalling. Mol Cell Biochem 182:59-63, 1998
43. Esposito DL, Li Y, Cama A, Quon MJ: Tyr(612) and Tyr(632) in human insulin receptor substrate-1 are important for full activation of insulin-stimulated phosphatidylinositol 3-kinase activity and translocation of GLUT4 in adipose cells. Endocrinology 142:2833-2840, 2001